Abstract
Major surface-iodinated proteins of Mr 105,000 and 145,000 of normal human neutrophils are immunoprecipitated by a number of monoclonal antibodies (AHN-1 to AHN-6), which react specifically with granulocytes among peripheral blood cells and selectively inhibit phagocytosis. These proteins, and an Mr 60,000 component, were purified by monoclonal antibody affinity chromatography, molecular sieve chromatography, and preparative polyacrylamide gel electrophoresis. Each of the three purified proteins was immunoprecipitated by all six antibodies. Nevertheless, tryptic peptide maps of the three proteins indicated that each was a distinct component. AHN-1 to AHN-6 also bound to glycolipid fractions of human neutrophils, and the binding of each antibody to human neutrophils was blocked by the carbohydrate sequences, lacto-N-fucopentaose III. The data indicate that a predominant antigenic determinant of human neutrophils is lacto-N-fucopentaose III, or related carbohydrates, present on three distinct proteins as well as glycolipids. At least one of these molecules appears to be involved in the process of phagocytosis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 263-271 |
| Number of pages | 9 |
| Journal | Archives of Biochemistry and Biophysics |
| Volume | 238 |
| Issue number | 1 |
| DOIs | |
| State | Published - Apr 1985 |
Bibliographical note
Funding Information:of Health Grants ROl-CA-36248 and ROl-GM-31158, the Minnesota Medical Foundation, and the Masonic Memorial Hospital Fund Inc. Dr. Skubitz is a fellow of the Leukemia Society of America.
Funding Information:
We thank Dr. Wade Gibson for use of the preparative gel electrophoresis apparatus; Jeffrey Chen and Wayne Pan for assistance in performing the tryptic peptide maps; Dr. Victor Ginsburg for providing purified lacto-N-fucopentaose I and III; Dr. James Hildreth for providing monoclonal antibodies MHM-23, MHM-24, H52, H5B9, H4C2, and H5A4; Dr. Daniel Kiehart for providing molecular weight standards and five IgM monoclonal antibodies, DP-1 to DP-5, with no reactivity to neutrophils; Donald W. Northfelt and Dr. William Aronstein for reviewing the manuscript; and Dagmar Kamprud for editing the manuscript. This work was supported in part by American Cancer Society Institutional Research Grant IN-13-V-30, University of Minnesota Graduate School Grant-in-Aid 0325-4909-73, National Institutes